SIG001

SIG001 · Peking University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SIG001, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: The Phase I Study of SIG001 Antibody on Cancer Therapy. [Phase 1]